🇺🇸 FDA
Patent

US 11634463

Methods and compositions for treating hemophilia

granted A61KA61K48/00A61P

Quick answer

US patent 11634463 (Methods and compositions for treating hemophilia) held by Sangamo Therapeutics, Inc. expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K48/00, A61P, A61P3/00, A61P43/00